Skip to main content
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1993 Feb;52(2):406–413.

Molecular analyses of a tyrosinase-negative albino family.

K C Park 1, C D Chintamaneni 1, R Halaban 1, C J Witkop Jr 1, B S Kwon 1
PMCID: PMC1682201  PMID: 8430701

Abstract

Sequence analysis of the tyrosinase coding region from an individual with tyrosinase-negative oculocutaneous albinism revealed that the patient was a compound heterozygote. One allele carried a C--> A single-base substitution in codon 355 of exon 3, and the other carried a two-nucleotide deletion in exon 1. The nucleotide substitution caused a putative amino acid change from threonine (ACA) to lysine (AAA), abolishing a signal for N-glycosylation. The two base-pair deletion caused a frameshift, creating a putative premature termination signal at codon 226. The melanocytes from the proband and her affected brother were amelanotic and devoid of measurable tyrosinase activity. Moreover, gel electrophoretic analysis of the immunoprecipitated proband tyrosinase showed that the protein was not processed to the mature glycosylated form, confirming the predicted consequence of the amino acid change. The two-base deletion on the homologous allele was detected only by sequencing genomic DNA. The transcript of this allele was not represented in the cDNA library and could not be detected by PCR mRNA, and the putative truncated protein (approximately 25 kDa) was not present in immunoprecipitates, suggesting that the allele with the missense mutation may be preferentially expressed.

Full text

PDF
406

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burnett J. B., Seiler H., Brown I. V. Separation and characterization of multiple forms of tyrosinase from mouse melanoma. Cancer Res. 1967 May;27(5):880–889. [PubMed] [Google Scholar]
  2. Chintamaneni C. D., Halaban R., Kobayashi Y., Witkop C. J., Jr, Kwon B. S. A single base insertion in the putative transmembrane domain of the tyrosinase gene as a cause for tyrosinase-negative oculocutaneous albinism. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5272–5276. doi: 10.1073/pnas.88.12.5272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chintamaneni C. D., Ramsay M., Colman M. A., Fox M. F., Pickard R. T., Kwon B. S. Mapping the human CAS2 gene, the homologue of the mouse brown (b) locus, to human chromosome 9p22-pter. Biochem Biophys Res Commun. 1991 Jul 15;178(1):227–235. doi: 10.1016/0006-291x(91)91803-k. [DOI] [PubMed] [Google Scholar]
  4. Giebel L. B., Spritz R. A. RFLP for MboI in the human tyrosinase (TYR) gene detected by PCR. Nucleic Acids Res. 1990 May 25;18(10):3103–3103. doi: 10.1093/nar/18.10.3103-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Halaban R., Ghosh S., Duray P., Kirkwood J. M., Lerner A. B. Human melanocytes cultured from nevi and melanomas. J Invest Dermatol. 1986 Jul;87(1):95–101. doi: 10.1111/1523-1747.ep12523594. [DOI] [PubMed] [Google Scholar]
  6. Halaban R., Moellmann G. Murine and human b locus pigmentation genes encode a glycoprotein (gp75) with catalase activity. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4809–4813. doi: 10.1073/pnas.87.12.4809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Halaban R., Pomerantz S. H., Marshall S., Lambert D. T., Lerner A. B. Regulation of tyrosinase in human melanocytes grown in culture. J Cell Biol. 1983 Aug;97(2):480–488. doi: 10.1083/jcb.97.2.480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hearing V. J., Nicholson J. M., Montague P. M., Ekel T. M., Tomecki K. J. Mammalian tyrosinase. Structural and functional interraltionship of isozymes. Biochim Biophys Acta. 1978 Feb 10;522(2):327–339. doi: 10.1016/0005-2744(78)90067-0. [DOI] [PubMed] [Google Scholar]
  9. Imokawa G., Mishima Y. Importance of glycoproteins in the initiation of melanogenesis: an electron microscopic study of B-16 melanoma cells after release from inhibition of glycosylation. J Invest Dermatol. 1986 Sep;87(3):319–325. doi: 10.1111/1523-1747.ep12524388. [DOI] [PubMed] [Google Scholar]
  10. King R. A., Mentink M. M., Oetting W. S. Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism. Mol Biol Med. 1991 Feb;8(1):19–29. [PubMed] [Google Scholar]
  11. King R. A., Olds D. P. Hairbulb tyrosinase activity in oculocutaneous albinism: suggestions for pathway control and block location. Am J Med Genet. 1985 Jan;20(1):49–55. doi: 10.1002/ajmg.1320200108. [DOI] [PubMed] [Google Scholar]
  12. King R. A., Summers C. G. Albinism. Dermatol Clin. 1988 Apr;6(2):217–228. [PubMed] [Google Scholar]
  13. Kwon B. S., Haq A. K., Pomerantz S. H., Halaban R. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7473–7477. doi: 10.1073/pnas.84.21.7473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Miyazaki K., Otaki N. Tyrosinase as glycoprotein. Arch Dermatol Forsch. 1975;252(3):211–216. doi: 10.1007/BF00557921. [DOI] [PubMed] [Google Scholar]
  15. Müller G., Ruppert S., Schmid E., Schütz G. Functional analysis of alternatively spliced tyrosinase gene transcripts. EMBO J. 1988 Sep;7(9):2723–2730. doi: 10.1002/j.1460-2075.1988.tb03126.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Oetting W. S., Handoko H. Y., Mentink M. M., Paller A. S., White J. G., King R. A. Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism. J Invest Dermatol. 1991 Jul;97(1):15–19. doi: 10.1111/1523-1747.ep12477808. [DOI] [PubMed] [Google Scholar]
  17. Oetting W. S., Mentink M. M., Summers C. G., Lewis R. A., White J. G., King R. A. Three different frameshift mutations of the tyrosinase gene in type IA oculocutaneous albinism. Am J Hum Genet. 1991 Jul;49(1):199–206. [PMC free article] [PubMed] [Google Scholar]
  18. Pomerantz S. H. L-tyrosine-3,5-3H assay for tyrosinase development in skin of newborn hamsters. Science. 1969 May 16;164(3881):838–839. doi: 10.1126/science.164.3881.838. [DOI] [PubMed] [Google Scholar]
  19. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Shibahara S., Tomita Y., Sakakura T., Nager C., Chaudhuri B., Müller R. Cloning and expression of cDNA encoding mouse tyrosinase. Nucleic Acids Res. 1986 Mar 25;14(6):2413–2427. doi: 10.1093/nar/14.6.2413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Shibahara S., Tomita Y., Tagami H., Müller R. M., Cohen T. Molecular basis for the heterogeneity of human tyrosinase. Tohoku J Exp Med. 1988 Dec;156(4):403–414. doi: 10.1620/tjem.156.403. [DOI] [PubMed] [Google Scholar]
  22. Spritz R. A., Strunk K. M., Giebel L. B., King R. A. Detection of mutations in the tyrosinase gene in a patient with type IA oculocutaneous albinism. N Engl J Med. 1990 Jun 14;322(24):1724–1728. doi: 10.1056/NEJM199006143222407. [DOI] [PubMed] [Google Scholar]
  23. Spritz R. A., Strunk K. M. RFLP for BgIII at the human tyrosinase (TYR) locus. Nucleic Acids Res. 1990 Jun 25;18(12):3672–3672. doi: 10.1093/nar/18.12.3672-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Spritz R., Strunk K., Oetting W., King R. RFLP for TaqI at the human tyrosinase locus. Nucleic Acids Res. 1988 Oct 25;16(20):9890–9890. doi: 10.1093/nar/16.20.9890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tomita Y., Takeda A., Okinaga S., Tagami H., Shibahara S. Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene. Biochem Biophys Res Commun. 1989 Nov 15;164(3):990–996. doi: 10.1016/0006-291x(89)91767-1. [DOI] [PubMed] [Google Scholar]
  26. Yamamoto H., Takeuchi T. Immunoelectron microscopic localization of tyrosinase in the mouse melanocyte. J Histochem Cytochem. 1981 Aug;29(8):953–958. doi: 10.1177/29.8.6792273. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES